Quantum Drug Discovery

MoleculeGen

102x faster molecular screening powered by 913 IBM Heron qubits. From target identification to lead optimization in a single quantum-accelerated pipeline.

102x
Faster
913
Qubits
20
NGC Integrations
12.5ms
Per Molecule

Quantum-Accelerated Discovery

Four-stage pipeline from target identification to optimized lead compounds, powered by variational quantum eigensolver circuits.

Step 01

Target ID

Identify disease-relevant protein targets using quantum-enhanced binding pocket analysis. Leverages VQE ground-state estimation to compute protein folding energies with chemical accuracy (<1.6 mHa).

Step 02

Quantum Screen

Screen candidate molecules against target using quantum molecular simulations. Evaluates binding affinity, ADMET properties, and toxicity in parallel across 6 Heron backends at 12.5ms per molecule.

Step 03

ADC-Linker

Design antibody-drug conjugate linkers with quantum-optimized stability. Simulates linker-payload bond energies and cleavage kinetics to maximize therapeutic index while minimizing off-target effects.

Step 04

Lead Optimize

Multi-objective optimization of lead compounds using quantum annealing and QAOA. Simultaneously optimizes potency, selectivity, solubility, metabolic stability, and synthetic accessibility scores.

Technical Specifications

Built for production-grade quantum chemistry with hardware-accelerated simulation.

Supported Molecules

  • Small molecules (drug-like, Lipinski-compliant)
  • Peptides up to 50 residues
  • Metal-organic complexes
  • ADC linker-payloads
  • SMILES, InChI, MOL2, SDF input formats

Computational Limits

  • Max atoms200 heavy atoms
  • Max qubits156 per circuit
  • Batch size10,000 molecules/job
  • Backends6 IBM Heron R2
  • Throughput~80 molecules/sec

Quantum Methods

  • Basis setsSTO-3G, 6-31G, cc-pVDZ
  • AnsatzUCCSD, ADAPT-VQE, HEA
  • OptimizerCOBYLA, L-BFGS-B, SPSA
  • QECFidelity-first error mitigation
  • ScoringAffinity, toxicity, solubility, ADMET

Build With MoleculeGen

Integrate quantum molecular screening into your existing workflows with our SDK, API, or Salesforce connector.

Python SDK

Native Python client with async support, auto-retry, and streaming results.

from epochcore import MoleculeGen mg = MoleculeGen(api_key="YOUR_KEY") results = mg.screen( smiles=["CC(=O)Oc1ccccc1C(=O)O"], target="EGFR", basis_set="sto-3g" ) print(results.binding_affinity)

REST API

OpenAPI 3.1-compliant endpoints. JSON in, JSON out. Works with any HTTP client.

curl -X POST \ /v1/moleculegen/screen \ -H "Authorization: Bearer KEY" \ -d '{ "smiles": ["..."], "target_protein": "EGFR", "basis_set": "sto-3g" }'

Salesforce Apex

Direct integration with Salesforce Health Cloud and Life Sciences for clinical pipeline management.

EpochCore.MoleculeScreen req = new EpochCore.MoleculeScreen(); req.smiles = new List<String>{ 'CC(=O)Oc1ccccc1C(=O)O' }; req.targetProtein = 'EGFR'; EpochCore.ScreenResult res = EpochCore.MoleculeGenAPI.screen(req);

Start Screening Today

Run your first quantum molecular screening in under 60 seconds. No GPU required -- our 913-qubit backend handles the heavy lifting.